Clinical Trial Update: Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients

View source ↗

Summary

A completed clinical trial update examining why mycophenolate mofetil doses were reduced in renal transplant recipients and how these reductions affected graft …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Rejection
• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Acute Rejection of Renal Transplant, Renal Graft Loss | Status: COMPLETED